Vanguard reports a Molina Healthcare (MOH) stake with sole voting power over 7,541 shares.
Vanguard Portfolio Management has filed an amended beneficial-ownership report for Molina Healthcare (MOH), disclosing a 4.44% stake, or 2,320,909 shares, as of September 30, 2026. The report specifies that Vanguard holds sole voting power over 7,541 shares and sole dispositive power over all 2,320,909 shares. This position includes securities held by various Vanguard funds and client accounts.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) shares rose 2.93% to $204.78 on Friday, despite a challenging day for the broader market. This marked the stock's second consecutive day of gains, outperforming the S&P 500 Index and the Dow Jones Industrial Average.
Molina Healthcare, Inc. (MOH) Seasonal returns chart
This article from Yahoo Finance displays a seasonal returns chart for Molina Healthcare, Inc. (MOH), showing the average monthly price return between 2016 and 2026. The page also provides current stock information, including the delayed quote from NYSE and pre-market activity.
Molina Healthcare, Inc. (MOH) Seasonal Returns Chart - Yahoo Finance
The article provides a seasonal returns chart for Molina Healthcare, Inc. (MOH), detailing average monthly price returns from 2016 to 2026. It includes current stock data such as the price, daily change, and after-hours trading information. The page also features navigation to various financial data points for MOH, including news, research, and historical data.
Molina Healthcare of Michigan Donates $15,000 to Provide Meals for Families Staying at COTS’ Peggy's Place
Molina Healthcare of Michigan has donated $15,000 to COTS (Coalition On Temporary Shelter) to provide nutritious meals for adults staying at Peggy's Place, an emergency shelter for families experiencing homelessness in Detroit. This funding addresses a critical gap in federal support, which typically only covers meals for children. The donation will ensure consistent meal service for adults, allowing families to focus on securing stable housing and employment.
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
DaVita's Community Health Experience program provides free health screenings and education directly within communities, aiming to identify hidden health risks like hypertension, diabetes, and chronic kidney disease (CKD) earlier. This year, nearly 1,000 people were screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease risk. The initiative connects participants with follow-up care and resources, empowering them to take proactive steps for their health.
HCA reports upbeat quarterly results on medical services demand
HCA Healthcare exceeded Wall Street expectations for its third-quarter results due to strong demand for medical services, despite an increase in uninsured patients impacting income. The company now anticipates its full-year 2026 financial performance to be in the upper half of its previously forecast range, with significant growth in admissions and revenue. This positive outlook comes despite federal policy changes that have led to more patients losing health insurance coverage.
Centene exiting Hawaii’s Med-QUEST program at end of year
National health insurer Centene is pulling its 'Ohana Health Plan out of Hawaii’s Med-QUEST Medicaid market, effective December 31, 2026, impacting 24,000 members. The company cited rising medical costs, inadequate reimbursement rates, and federal funding changes as reasons for its withdrawal. Affected members will need to select a new health plan, and Med-QUEST will automatically assign a plan if no selection is made, ensuring continued coverage.
HCA Healthcare beats quarterly profit estimates on demand for medical services
HCA Healthcare exceeded Wall Street's third-quarter profit estimates due to strong demand for medical services, despite an increase in uninsured patients. The hospital operator's shares rose, and the company now expects its full-year 2026 financial results to be in the upper half of its previously forecast range. Revenue and admissions also increased, signaling a positive outlook for the company despite challenges from federal policy changes.
Molina Healthcare Inc. stock underperforms Tuesday when compared to competitors
Molina Healthcare Inc. (MOH) shares fell 2.60% on Tuesday, closing at $199.46, despite a positive trading session for the broader market. This marked the third consecutive day of losses for the stock. The S&P 500 Index rose 0.60%, and the Dow Jones Industrial Average gained 0.03% on the same day.
Molina Healthcare Inc. stock underperforms Monday when compared to competitors
Molina Healthcare Inc. (MOH) shares fell by 2.08% on Monday, closing at $204.79, despite a generally favorable trading session for the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average saw gains. This marks the second consecutive day of losses for Molina Healthcare's stock.
57% estimate fraud, waste and abuse costs about $100B-$499B yearly. 30% want AI to flag claims.
A new Aetna Q3 provider survey by CVS Health reveals an average payer-provider trust score of 6.0, consistent with improvements seen in Q2. The survey highlights that administrative burden, though still a challenge, is declining, with real-time patient information identified as the next key area for improvement. Additionally, nearly all providers agree that addressing fraud, waste, and abuse, estimated to cost $100B-$499B annually, can significantly lower healthcare costs, with 30% recommending AI for flagging suspicious claims.
Molina Healthcare Inc Estimates – NYSE:MOH
This article provides an overview of Molina Healthcare Inc (NYSE: MOH) on TradingView, focusing on its financial data and analyst estimates. Users can explore reported financial information and compare actual results with average, high, and low estimates across various financial statements and valuation metrics. The platform also allows visualization of financial trends over time.
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $217.35
The average 12-month price target for Molina Healthcare Inc (MOH) stock has increased from $215.88 to $217.35, based on estimates from 17 analysts. Forecasts for the stock range from $156 to $266 per share, while the consensus rating remains "Hold" among 22 covering analysts.
Centene sues federal health agencies over Medicare Advantage star ratings that could cost it $448M
Centene Corp. is suing federal health agencies over Medicare Advantage star ratings, alleging that the Centers for Medicare & Medicaid Services (CMS) adopted 17 measures without required rulemaking. The health insurer claims these star ratings could cost the company $448 million, noting that several of its contracts would otherwise improve from 3.5 to four stars.
Jefferies raises Molina Healthcare stock price target on 2027 rate data
Jefferies has increased its price target for Molina Healthcare (NYSE:MOH) to $220 from $205, maintaining a Hold rating, driven by favorable 2027 rate data, including an average 7% rate increase for 80% of premiums. Despite the stock trading near this new target, InvestingPro analysis suggests the company is undervalued with a Fair Value of $271.91. The firm noted that while third-quarter Medicaid medical loss ratio missed expectations, other segments were in line, and management's share buybacks and a strong balance sheet are positive indicators, though Jefferies seeks more conservative assumptions for a rating change.
Molina Healthcare Inc. stock underperforms Friday when compared to competitors
Molina Healthcare Inc. (MOH) stock fell 3.46% on Friday, closing at $209.15, underperforming the broader market as the S&P 500 and Dow Jones also declined. The company's shares are currently 14.59% below their 52-week high.
Humana, UnitedHealthcare ending Medicare Advantage plans for 1 million seniors, insurers say
Humana and UnitedHealthcare are discontinuing some Medicare Advantage plans, affecting approximately 1 million seniors starting next year. Humana's decision impacts about 600,000 enrollees, while UnitedHealthcare is closing a plan for roughly 390,000 members, citing higher costs and increased plan usage across the healthcare industry. Both insurers stated that most affected members would be offered alternative plans.
Results: Molina Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Molina Healthcare, Inc. (NYSE:MOH) recently surpassed its quarterly earnings expectations, reporting a 3.1% revenue increase to US$9.0 billion and a statutory earnings per share (EPS) of US$5.00, significantly above analyst estimates. Following these strong results, analysts have updated their forecasts for the company, with the average price target rising to US$437. This article details the financial performance, analyst sentiment, and potential implications for investors.
Elevance Earns $1.4 Billion Quarterly Profit as Membership Falls by 487,000 and Insurer Calls 2026 the Medicaid Trough
Elevance Health reported a $1.4 billion third-quarter profit despite a 487,000 decrease in membership, primarily due to changes in its Medicaid business. The insurer projects 2026 as the low point for Medicaid profit margins, expecting improvement in 2027 as it exits some markets, tightens spending, and prepares for new federal work requirements. These changes will significantly impact Medicaid members, who may face new doctors, approval processes, and re-enrollment challenges.
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $216.41
Molina Healthcare Inc.'s average 12-month price target has increased from $214.94 to $216.41, according to 17 analysts, with forecasts ranging from $147 to $266 per share. The consensus rating among 22 covering analysts remains "Hold," with 4 Buys, 17 Holds, and 1 Sell recommendation. Investors can find more detailed price target data and analyst recommendations on TradingView's platform.
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $216.41, Implies 1% Downside
Molina Healthcare Inc.'s average 12-month price target has increased from $214.94 to $216.41, based on estimates from 17 analysts, with forecasts ranging from $147 to $266 per share. The consensus rating for MOH remains "Hold" among 22 covering analysts, comprising 4 Buys, 17 Holds, and 1 Sell. This updated target implies a slight 1% downside.
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $215.06, Implies 1% Downside
Molina Healthcare Inc.'s average price target has increased to $215.06 from $213.59, based on estimates from 17 analysts. This updated target suggests a potential 1% downside from the October 22 closing price. The consensus analyst rating for Molina Healthcare Inc. remains "Hold" among 22 covering analysts.
Centene to Report Q3 Earnings: Buy, Sell or Hold the Stock?
Centene Corporation (CNC) is scheduled to report its third-quarter 2026 earnings before the opening bell on October 27. The Zacks Consensus Estimate projects a significant year-over-year decline in Q3 earnings and revenues, despite the company's strong track record of beating earnings estimates in the past four quarters. While Centene's Medicaid margins and Marketplace profitability are improving, declining memberships and persistent cost pressures present a mixed investment outlook, suggesting existing investors may hold and new investors await a better entry point.
Molina Healthcare Reports Q3 2026 Net Income Decline to $38M Amid Revenue Drop
Molina Healthcare, Inc. (NYSE:MOH) reported a significant decline in net income to $38 million for Q3 2026, down from $79 million in Q3 2025, according to its Form 10-Q filing. Total revenue also decreased to $11,082 million from $11,477 million in the prior year, leading to diluted EPS of $0.73 compared to $1.51. The company also recorded a $93 million impairment charge for the nine months ended September 30, 2026.
Cantor Fitzgerald reiterates Molina Healthcare stock rating at neutral
Cantor Fitzgerald reiterated a Neutral rating for Molina Healthcare (NYSE:MOH) with a $209.00 price target, despite the stock trading at $214.90 and InvestingPro suggesting it's undervalued. The company reported strong third-quarter 2026 earnings but did not raise its full-year guidance, implying a lower-than-expected fourth-quarter EPS, potentially due to conservatism or new pressures in Florida. Molina Healthcare's stock has seen a 40% return over the past six months, and the company recently surpassed Q3 2026 earnings and revenue expectations but anticipates a softer revenue outlook for 2027.
Centene to Report Q3 Earnings: Buy, Sell or Hold the Stock?
Centene Corporation (CNC) is set to report its third-quarter 2026 earnings, with Zacks analysts projecting a year-over-year decline in both earnings per share and revenues, despite a strong historical earnings surprise record. The company faces challenges from decreasing commercial and Medicaid memberships but benefits from improving Medicaid margins and Marketplace profitability. While Centene's stock has significantly outperformed its industry and the S&P 500 year-to-date, its current valuation is considered elevated, suggesting existing investors might hold while new investors could wait for a better entry point.
Earnings call transcript: Molina Healthcare tops Q3 2026 estimates, shares slip
Molina Healthcare reported strong third-quarter 2026 results, exceeding Wall Street expectations for adjusted earnings and revenue. Despite the beat, shares slipped 1.95% in premarket trading due to a softer preliminary 2027 revenue outlook and anticipated near-term cost pressures from a new Florida CMS contract. The company reaffirmed its full-year 2026 guidance and expressed confidence in improving Medicaid margins due to recent rate updates and stable medical cost trends.
Molina Healthcare Q3 2026 Earnings Call Transcript
Molina Healthcare reported adjusted EPS of $0.89 and $10.5 billion in premium revenue for Q3 2026, reaffirming its full-year guidance of approximately $42 billion in premium revenue and at least $5.25 adjusted EPS. The company also provided a preliminary 2027 outlook, anticipating at least $45 billion in premium revenue and over $9.50 per share in adjusted earnings, despite expected delays in new Medicaid contracts in Georgia and Texas. Management expressed cautious optimism regarding rate increases capturing cost trends and potential margin improvements, especially in its Medicaid and duals-focused Medicare businesses.
Molina Healthcare Slides as Investors Brace for Earnings and Ongoing Margin Pressure
Molina Healthcare (MOH) shares fell 4.4% today due to investor caution ahead of its Q3 2026 earnings release and ongoing concerns about Medicaid margin pressure and 2026 earnings headwinds. The company is grappling with a new Florida Medicaid contract's profit drag and plans to exit its traditional MAPD product in 2027. Broader market sentiment in managed care remains fragile amidst elevated medical costs and profitability pressures.
UnitedHealthcare, Humana Medicare Advantage cancellations to affect 1M
UnitedHealthcare and Humana are canceling Medicare Advantage plans, impacting nearly one million people, primarily through Preferred Provider Organizations. This move, driven by high healthcare usage and rising medical costs, is intended to protect corporate profits as Medicare enrollment season begins. Patients may face fewer benefits, restricted provider networks, and higher out-of-pocket expenses, although specialized plans for severe illnesses are expanding.
Molina Healthcare Slides as Investors Brace for Earnings and Ongoing Margin Pressure
Molina Healthcare's stock declined as investors anticipated upcoming earnings, with a particular focus on potential margin pressure from the company's Medicare and Medicaid businesses. Analysts have noted that Molina could face headwinds from changes in competitive dynamics and redetermination processes affecting membership, although these impacts may be somewhat offset by improved medical cost trends. The stock's current valuation appears to reflect some of these anticipated challenges.
Molina Healthcare falls 4% on challenging environment, despite beating third quarter estimates
Molina Healthcare Inc. reported adjusted earnings per share of $0.89 and revenue of $11.08 billion for the third quarter, exceeding analyst estimates. Despite beating expectations, the company's shares fell 4.6% due to investor concerns over a challenging operating environment and compressed margins, with the consolidated medical care ratio rising to 92.9%. The company reaffirmed its full-year 2026 adjusted earnings guidance of at least $5.25 per share, anticipating a "turn in Medicaid margins" despite expected losses from a new Florida Medicaid contract and exiting a Medicare Advantage product.
Molina Healthcare Inc. stock underperforms Wednesday when compared to competitors
Molina Healthcare Inc. (MOH) stock fell by 2.19% on Wednesday, closing at $214.90, despite a positive trading session for the broader market where the S&P 500 and Dow Jones Industrial Average both saw gains. This decline broke a two-day winning streak for the company's shares.
Form 8-K MOLINA HEALTHCARE, INC. For: Oct 21
Molina Healthcare, Inc. filed a Form 8-K on October 21, 2026, to report its financial results for the third quarter ended September 30, 2026. The company reaffirmed its full-year 2026 earnings guidance. The press release containing the full financial results is included as Exhibit 99.1 to the report.
Molina Healthcare Reports Third Quarter 2026 Financial Results
Molina Healthcare reported third-quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. The company reaffirmed its full-year 2026 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share. Despite a decrease in premium revenue and net income year-over-year, management expressed optimism regarding the apparent plateauing of medical cost trends and strong 2027 rate updates.
Molina Healthcare Reports Third Quarter 2026 Financial Results
Molina Healthcare reported its third-quarter 2026 financial results, with GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. The company reaffirmed its full-year 2026 guidance, expecting approximately $42 billion in premium revenue and at least $5.25 in adjusted earnings per diluted share. Despite a challenging environment, management expressed optimism about the apparent plateauing of medical cost trends and strong 2027 rate updates, suggesting a potential turn in Medicaid margins.
Molina Healthcare earnings in focus as Medicaid pressures mount
Molina Healthcare (MOH) is expected to report a significant sequential decline in third-quarter earnings, with analysts forecasting $0.79 per share on $10.86 billion in revenue, driven by Medicaid enrollment pressures and rising medical costs. Investors will closely watch Medicaid enrollment trends and the company's ability to manage medical costs, especially as new work requirements for Medicaid take effect in January 2027. Despite a strong prior quarter, the insurer faces challenges maintaining profitability and rebuilding investor confidence amidst an uncertain market.
Molina Healthcare, Inc. (MOH) Stock Price, News, Quote & History
Molina Healthcare, Inc. (MOH) closed at $214.90, down 2.19%, with an after-hours trading price of $203.00, down 5.54%. The company is scheduled to hold its Q3 2026 earnings call on October 22, 2026, at 8 a.m. EDT. Molina Healthcare provides managed healthcare services, primarily to low-income families through Medicaid and Medicare programs, and has shown a YTD return of 23.83% compared to the S&P 500's 13.32%.
Molina Healthcare schedules October 21 results. Molina Healthcare stock gains 5.27 percent
Molina Healthcare has scheduled its third-quarter 2026 results for October 21, 2026, after reporting a 4.80 percent decline in second-quarter revenue. The stock saw a 5.27 percent gain on the NYSE, trading at EUR 196.43 on October 20, 2026. Analysts expect third-quarter revenue of USD 10.86 billion and earnings of USD 0.79 per share, setting a near-term test for the company.
Molina Healthcare schedules October 21 results. Molina Healthcare stock gains 5.27 percent
Molina Healthcare is scheduled to release its third-quarter 2026 results on October 21, 2026, following a weaker second quarter where revenue declined by 4.80 percent. The stock gained 5.27 percent on the NYSE, trading at EUR 196.43 on October 20, 2026. Analysts anticipate third-quarter revenue of USD 10.86 billion and earnings of USD 0.79 per share.
UnitedHealth Sees Commercial Plan Cost Increases Rising Over 11%
UnitedHealth Group executives report that commercial health insurance plan costs are expected to increase by over 11% in 2026, exceeding initial expectations due to specialty drugs, higher clinician costs, and the No Surprises Act. Employers should anticipate significant health coverage price increases. Despite these rising costs, UnitedHealthcare's sales and group retention rates for large and midsize employer plans remain strong.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) shares increased by 4.53% to $219.72 on Tuesday, outperforming its competitors. The rise occurred on a strong trading day where the S&P 500 Index also gained 0.28% and the Dow Jones Industrial Average rose by 1.02%. This marked the second consecutive day of gains for the company's stock.
CNC Stock Price and Chart — NYSE:CNC
This article provides a comprehensive overview of Centene Corporation (NYSE: CNC) stock, including its current price, historical performance, key financial stats, and company information. It also features analyst ratings, investment ideas from the TradingView community, and responses to frequently asked questions about the stock. The article highlights Centene's role as a healthcare enterprise offering services through various segments like Medicaid, Medicare, and Commercial.
Molina Healthcare, Inc. (MOH) stock price, news, quote and history
Molina Healthcare, Inc. (MOH) stock closed at $219.72, up 4.53%, on October 20, 2026. The company is set to release its Q3 2026 earnings on October 22, 2026. Molina Healthcare provides managed healthcare services primarily to low-income families through Medicaid, Medicare, and state insurance marketplaces.
Best Medicare Part D Prescription Drug Plans: Updated for 2027
NerdWallet evaluated Medicare Part D plans for 2027, highlighting Humana as the best overall provider due to its affordability, high quality, and member satisfaction. Wellcare was recognized for offering the lowest premiums, while HealthSpring stood out for its relatively low costs on non-preferred drugs. The article advises consumers to check formularies, pharmacy networks, and plan changes using Medicare.gov to find the most suitable plan for their specific needs.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) shares rose 1.37% to $210.20 on Monday, outperforming the broader market despite a mixed trading session. The company's stock closed 14.17% below its 52-week high of $244.89 achieved in July.
Stock picks in the health care equipment and services sector by Oppenheimer (IHF:NYSEARCA)
Oppenheimer has upgraded the health care equipment and services sector to "overweight" from "market weight" due to a more positive outlook on the sector's performance. The firm's technical analysis indicates that the industry is poised for a reversal to higher growth after a year-long base. This upgrade suggests a favorable view of companies within this sector, including those represented by ETFs like IHF.
17 analysts set a USD 202.44 target for Molina Healthcare stock
Seventeen analysts have set an average 12-month target of USD 202.44 for Molina Healthcare (MOH) stock, which is 2.37 percent below its last trading price of USD 207.36 as of October 16, 2026. The company's market capitalization stands at USD 10.8 billion, with a 52-week trading range of USD 121.06 to USD 244.89. Molina Healthcare is scheduled to report its results on October 21, 2026, and analysts currently hold a "Hold" consensus on the stock.
MOH5003223 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the Molina Healthcare, Inc. 4.375% 15-JUN-2028 bond, identified as MOH5003223. It outlines key facts such as the issuer, issue and maturity dates, face value, and minimum denomination. The profile also details interest payment information, including the fixed coupon rate, semi-annual frequency, and upcoming payout schedule, along with bond redemption details like the outstanding amount and redemption type.
